Pulse Biosciences (PLSE) Notes Payables (2021 - 2023)

Pulse Biosciences' Notes Payables history runs 3 years deep, the most recent figure standing at $801000.0 for Q1 2023.

• On a quarterly basis, Notes Payables changed N/A year-over-year to $801000.0 in Q1 2023; TTM through Mar 2023 was $801000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $917000.0, changed N/A from the prior year.
• Notes Payables declined to $801000.0 in Q1 2023 per PLSE's latest filing, from $917000.0 in the prior quarter.
• Across five years, Notes Payables topped out at $1.7 million in Q2 2021 and bottomed at $98000.0 in Q3 2022.
• The 3-year median for Notes Payables is $859000.0 (2022), against an average of $791666.7.
• Biggest YoY gain for Notes Payables was 90.98% in 2022; the steepest drop was 90.98% in 2022.
• Year by year, Notes Payables stood at $1.1 million in 2021, then fell by 15.56% to $917000.0 in 2022, then fell by 12.65% to $801000.0 in 2023.
• Per Business Quant, the three latest PLSE Notes Payables figures stand at $801000.0 (Q1 2023), $917000.0 (Q4 2022), and $98000.0 (Q3 2022).